
Stephanie Lynn (Downey) Goff MD FACS
Breast, Melanoma, Surgical Oncology (Other than Breast)
Staff Clinician, Surgery Branch, National Cancer Institute
Join to View Full Profile
177 Fort Washington AveMHB 7GS 313New York, NY 10032
Phone+1 813-787-4286
Dr. Goff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's HospitalFellowship, Complex General Surgical Oncology, 2012 - 2014
- Massachusetts General HospitalFellowship, Complex General Surgical Oncology, 2012 - 2014
- New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2009 - 2012
- National Cancer InstituteFellowship, Tumor Immunology, 2005 - 2009
- New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Surgery, 2003 - 2005
- University of South Florida College of MedicineClass of 2003
Certifications & Licensure
- NY State Medical License 2005 - 2025
- MA State Medical License 2012 - 2018
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- Publisher Correction: Neoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.Frank J Lowery, Stephanie L Goff, Billel Gasmi, Maria R Parkhurst, Nivedita M Ratnam
Nature Medicine. 2025-04-15 - Tumor-infiltrating lymphocyte immunotherapy comes of age: a journey of development in the Surgery Branch, NCI.Stephanie L Goff, Steven A Rosenberg
Journal for Immunotherapy of Cancer. 2025-04-09 - 1 citationsNeoantigen-specific tumor-infiltrating lymphocytes in gastrointestinal cancers: a phase 2 trial.Frank J Lowery, Stephanie L Goff, Billel Gasmi, Maria R Parkhurst, Nivedita M Ratnam
Nature Medicine. 2025-04-01
Press Mentions
- Combination Immunotherapy Shrank a Variety of Metastatic Gastrointestinal CancersApril 1st, 2025
- Understanding the Risk of Second Cancers After CAR T-cell TherapyAugust 13th, 2024
- Evidence Mounting for TILs as Possible First-Line Cancer TherapySeptember 24th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: